MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regulus Therapeutics Inc. - Common Stock (NQ:RGLS)

8.160 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.160
Bid (Size) 8.010 (4)
Ask (Size) 8.150 (5)
Prev. Close 8.160
Today's Range 8.160 - 8.160
52wk Range 0.8301 - 8.345
Shares Outstanding 87,040,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+423.1%
+423.1%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-0.7%
-0.7%
1 Year
+440.4%
+440.4%

More News

Read More
News headline image
REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead ↗
Via Stocktwits
Topics Stocks
News headline image
Wednesday's session: top gainers and losers ↗
Via Chartmill
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher ↗
Via Benzinga
News headline image
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million ↗
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill
News headline image
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results ↗
Via Benzinga
Topics Stocks
News headline image
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis ↗
Via Stocktwits
News headline image
RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Regulus Therapeutics Inc. - Common Stock publicly traded?
Yes, Regulus Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Regulus Therapeutics Inc. - Common Stock trade on?
Regulus Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Regulus Therapeutics Inc. - Common Stock?
The ticker symbol for Regulus Therapeutics Inc. - Common Stock is RGLS on the Nasdaq Stock Market
What is the current price of Regulus Therapeutics Inc. - Common Stock?
The current price of Regulus Therapeutics Inc. - Common Stock is 8.160
When was Regulus Therapeutics Inc. - Common Stock last traded?
The last trade of Regulus Therapeutics Inc. - Common Stock was at 06/24/25 04:00 PM ET
What is the market capitalization of Regulus Therapeutics Inc. - Common Stock?
The market capitalization of Regulus Therapeutics Inc. - Common Stock is 710.25M
How many shares of Regulus Therapeutics Inc. - Common Stock are outstanding?
Regulus Therapeutics Inc. - Common Stock has 710M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story